Viewing Study NCT06810960


Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-01-02 @ 6:48 AM
Study NCT ID: NCT06810960
Status: RECRUITING
Last Update Posted: 2025-05-31
First Post: 2025-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease
Sponsor: Eisai Korea Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module